The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1339
May 31, 2010
View Complete Issue         Table of Contents 2019 
Issue 1339
Subscribers: Log in to read full issue.  Not a subscriber?  Subscribe or purchase issue.
In Brief: Herpes Zoster Vaccine (Zostavax) Revisited
May 31, 2010 (Issue: 1339)
The 2006 Medical Letter article on the then-new varicella-zoster vaccine concluded that Zostavax appears to be safe and effective in protecting patients ≥60 years old against herpes zoster and postherpetic neuralgia, especially in reducing the...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this issue?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this issue:
Title: Issue 1339
 


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.